Oncology & Immunology

Monoclonal Antibodies / Immunotherapies

Pembrolizumab, Nivolumab, Adalimumab — targeted oncology & autoimmune biologics

5 common products5 with a HCPCS code
At a glance

Monoclonal Antibodies / Immunotherapies include Keytruda, Opdivo, Humira, Dupixent. Clinician-administered products in this class bill under J9271, J9299, J0135, J3490, J3357; the rest are dispensed by a pharmacy and billed on the NDC alone.

Common products in this class

KeytrudaOpdivoHumiraDupixentStelara

Billing codes for this class

HCPCS codes for Monoclonal Antibodies / Immunotherapies
DrugCodeBillable unit
KeytrudaJ92711 mg = 1 Unit
OpdivoJ92991 mg = 1 Unit
HumiraJ013520 mg = 1 Unit
DupixentJ3490Per syringe (300 mg)
StelaraJ33571 mg = 1 Unit

FDA records in this class

NDC 0310-4611RxImfinziLabelerAstraZeneca Pharmaceuticals LPFormInjection, solutionView details NDC 0006-3026RxKeytrudaLabelerMerck Sharp & Dohme LLCFormInjection, solutionView details NDC 0003-6120RxOpdivo qvantigLabelerE.R. Squibb & Sons, L.L.C.FormInjection, solutionView details NDC 44087-3535RxBavencioLabelerEMD Serono, Inc.FormInjection, solution, concentrateView details NDC 72579-125RxTevimbraLabelerBeOne Medicines USA, Inc.FormInjection, solution, concentrateView details NDC 72579-121RxTevimbraLabelerBeOne Medicines USA, Inc.FormInjection, solution, concentrateView details NDC 0003-3772RxOpdivoLabelerE.R. Squibb & Sons, L.L.C.FormInjectionView details NDC 0006-5083RxKeytruda qlexLabelerMerck Sharp & Dohme LLCFormInjection, solutionView details NDC 0003-3120RxOpdivo qvantigLabelerE.R. Squibb & Sons, L.L.C.FormInjection, solutionView details NDC 50242-917RxTecentriqLabelerGenentech, Inc.FormInjection, solutionView details NDC 50242-918RxTecentriqLabelerGenentech, Inc.FormInjection, solutionView details NDC 50242-933RxTecentriq HybrezaLabelerGenentech, Inc.FormInjectionView details NDC 0003-3734RxOpdivoLabelerE.R. Squibb & Sons, L.L.C.FormInjectionView details NDC 0006-3083RxKeytruda qlexLabelerMerck Sharp & Dohme LLCFormInjection, solutionView details NDC 70114-340RxLoqtorziLabelerCoherus Oncology, Inc.FormInjectionView details NDC 0003-7125RxOpdualagLabelerE.R. Squibb & Sons, L.L.C.FormInjectionView details NDC 0173-0898RxJemperliLabelerGlaxoSmithKline LLCFormInjectionView details NDC 70095-130RxUnloxcytLabelerSun Pharmaceutical Industries, Inc.FormInjection, solutionView details NDC 0003-3774RxOpdivoLabelerE.R. Squibb & Sons, L.L.C.FormInjectionView details NDC 50881-006RxZynyzLabelerIncyte CorporationFormInjectionView details

Next steps

Every NDC in this class

The full FDA registry filtered to monoclonal antibodies / immunotherapies, with packaging and billing crosswalks.

Open the directory

Trials in this area

Treatments still in Phase 1 to 3 for the same therapeutic area.

View the pipeline

Other classes

GLP-1 Receptor AgonistsHMG-CoA Reductase Inhibitors (Statins)SGLT2 InhibitorsBeta-Adrenergic BlockersNonsteroidal Anti-inflammatory Drugs (NSAIDs)CNS Stimulants & ADHD AgentsSSRIs & Antidepressants
All drug classes